Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9831)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2018 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Koike K. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. World J Gastroenterol 2018; 24(32): 3617-3625 [PMID: 30166857 DOI: 10.3748/wjg.v24.i32.3617] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i32/3617.htm |
| Number | Citing Articles |
| 1 |
Shahin Bolori, Saina Shegefti, Kaveh Baghaei, Abbas Yadegar, Kyung-Mee Moon, Leonard J. Foster, Mohammad Javad Nasiri, Hossein Dabiri, Enoc Mariano Cortés-Malagón. The Effects of Helicobacter pylori‐Derived Outer Membrane Vesicles on Hepatic Stellate Cell Activation and Liver Fibrosis In Vitro. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/4848643
|
| 2 |
Ting-Ting Huang, Yong-Xiao Cao, Lei Cao. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1418129
|
| 3 |
Yecui Zhang, Qiang Jia, Chenyang Hu, Mingming Han, Qiming Guo, Shumin Li, Cunxiang Bo, Yu Zhang, Xuejie Qi, Linlin Sai, Cheng Peng. Effects of chlorpyrifos exposure on liver inflammation and intestinal flora structure in mice. Toxicology Research 2021; 10(1): 141 doi: 10.1093/toxres/tfaa108
|
| 4 |
Hang Yang, Liwen Guan, Bing Hu, Leticia Moreira. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/4710964
|
| 5 |
Ahmed Hashim, Ahmed Maraey, Ahmed Elzanaty, Magdi Zordok, Hadeer Elsharnoby, Mahmoud Khalil, Omar Al Wahadneh, Helmy Siragy. Nonalcoholic Fatty Liver Disease Predicts Acute Kidney Injury Readmission in Heart Failure Hospitalizations: A Nationwide Analysis. Current Problems in Cardiology 2023; 48(10): 101816 doi: 10.1016/j.cpcardiol.2023.101816
|
| 6 |
Andrea Mirković, Nikola Savić. Medical treatment and prevention of Helicobacter pylori infection. Sestrinska vizija 2021; 5(9): 10 doi: 10.5937/SestrViz2109010M
|
| 7 |
Dragos Popa, Cosmin Obleagă, Bogdan Socea, Dragos Serban, Marius Ciurea, Marian Diaconescu, Ionică Vîlcea, Cristian Meșină, Cecil Mirea, Dan Nicolae Florescu, Vlad Baleanu, Meda Comandasu, Mihai Tudosie, Laura Tribus, Bogdan Niculescu. Role of Helicobacter pylori in the triggering and evolution of hemorrhagic gastro‑duodenal lesions. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10582
|
| 8 |
Chuandong Zhang, Yuqi Chen, Yan Long, Huimin Zheng, Jiyong Jing, Wensheng Pan. Helicobacter pylori and Gastrointestinal Cancers: Recent Advances and Controversies. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241234637
|
| 9 |
Rashid Abdel-Razeq, Lynn Bitar, Elio R Bitar, Chidera Onwuzo, Mohamad-Noor Abu-Hammour, Barish Eren, Islam Mohamed, Adejoke Johnson, Antoine Boustany, Somtochukwu Onwuzo, Imad Asaad. Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with <i>Helicobacter pylori</i> infection: A population-based study. World Journal of Hepatology 2024; 16(10): 1169-1176 doi: 10.4254/wjh.v16.i10.1169
|
| 10 |
Wei Yang, Yingying Liu, Ruoling Gao, Zenghe Xiu, Ting Sun. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance. Cellular Signalling 2019; 60: 122 doi: 10.1016/j.cellsig.2019.04.011
|
| 11 |
Fei Liu, Changfeng Sun, Yuanfang Chen, Fei Du, Yuxiang Yang, Gang Wu. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00032
|
| 12 |
Yoo Min Han, Jooyoung Lee, Ji Min Choi, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Goh Eun Chung, Daisuke Tokuhara. The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors. PLOS ONE 2021; 16(12): e0260994 doi: 10.1371/journal.pone.0260994
|
| 13 |
Kimberly Sánchez-Alonzo, Lillian Matamala-Valdés, Cristian Parra-Sepúlveda, Humberto Bernasconi, Víctor L. Campos, Carlos T. Smith, Katia Sáez, Apolinaria García-Cancino. Intracellular Presence of Helicobacter pylori and Its Virulence-Associated Genotypes within the Vaginal Yeast of Term Pregnant Women. Microorganisms 2021; 9(1): 131 doi: 10.3390/microorganisms9010131
|
| 14 |
Christian S. Alvarez, Andrea A. Florio, Julia Butt, Alvaro Rivera‐Andrade, María F. Kroker‐Lobos, Tim Waterboer, Maria Constanza Camargo, Neal D. Freedman, Barry I. Graubard, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramírez‐Zea, Katherine A. McGlynn. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020; 25(6) doi: 10.1111/hel.12756
|
| 15 |
Arsia Jamali, Shahrokh Karbalai, Ghazale Tefagh, Raika Jamali, Ayat Ahmadi. The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial. Middle East Journal of Digestive Diseases 2022; 14(1): 85 doi: 10.34172/mejdd.2022.260
|
| 16 |
Alessandro Mantovani, Teresa Turino, Anna Altomari, Amedeo Lonardo, Giacomo Zoppini, Luca Valenti, Herbert Tilg, Christopher D. Byrne, Giovanni Targher. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism 2019; 96: 56 doi: 10.1016/j.metabol.2019.04.012
|
| 17 |
Aakriti Soni, Anuroop Yekula, Yuvaraj Singh, Nitish Sood, Dushyant Singh Dahiya, Kannu Bansal, GM Abraham. Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis. World Journal of Hepatology 2023; 15(1): 79-88 doi: 10.4254/wjh.v15.i1.79
|
| 18 |
Milica Ristić, Bojan Korica, Vladimir Milivojević. Frequency of Helicobacter pylori infection and antibiotic resistance in patients with acute liver decompensation. Medicinski podmladak 2023; 74(5): 62 doi: 10.5937/mp74-39601
|
| 19 |
Yu Kyung Jun, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Yong Jin Jung, Won Kim, Hyun Sun Park, Dong Hyeon Lee, Seong-Joon Koh, Dario Ummarino. Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis. PLOS ONE 2022; 17(1): e0261448 doi: 10.1371/journal.pone.0261448
|
| 20 |
Bianca Laura Bernardoni, Concettina La Motta, Simone Carradori, Ilaria D’Agostino. Bacterial Carbonic Anhydrases. The Enzymes 2024; 55: 213 doi: 10.1016/bs.enz.2024.05.013
|
| 21 |
Xiaoyin Peng, Yumei Liang, Yan Liu, Juan Zhang, Yong Chen, Qi Zhang, Xiangchun Zeng, Li Huang. The Comparison of the Clinical Efficacy and Drug Tissue Distribution of Furazolidone and Tetracycline-quadruple Therapy in Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 2024; doi: 10.1097/MCG.0000000000002044
|
| 22 |
Anna-Klara Pettersson, Giola Santoni, Jacinth Yan, Cecilia Radkiewicz, Shaohua Xie, Helgi Birgisson, Eivind Ness-Jensen, My von Euler-Chelpin, Joonas H. Kauppila, Jesper Lagergren. Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP). Scandinavian Journal of Gastroenterology 2023; 58(5): 453 doi: 10.1080/00365521.2022.2144435
|
| 23 |
Marcello Candelli, Laura Franza, Rossella Cianci, Giulia Pignataro, Giuseppe Merra, Andrea Piccioni, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi. The Interplay between Helicobacter pylori and Gut Microbiota in Non-Gastrointestinal Disorders: A Special Focus on Atherosclerosis. International Journal of Molecular Sciences 2023; 24(24): 17520 doi: 10.3390/ijms242417520
|
| 24 |
Yong‐Wen Leow, Wah‐Kheong Chan. Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B. Journal of Viral Hepatitis 2023; 30(8): 712 doi: 10.1111/jvh.13858
|
| 25 |
Li Xiao, Qianyu Zhang, Yanshuang Peng, Daqing Wang, Ying Liu. The effect of periodontal bacteria infection on incidence and prognosis of cancer. Medicine 2020; 99(15): e19698 doi: 10.1097/MD.0000000000019698
|
| 26 |
T. E. Kugler, G. G. Taradin, I. V. Rakitskaya, A. L. Khristulenko, V. B. Gnilitskaya. Helicobacter infection and hepatobiliary cancer: epidemiology and pathogenesis. Experimental and Clinical Gastroenterology 2023; (12): 36 doi: 10.31146/1682-8658-ecg-220-12-36-46
|
| 27 |
T.S. Sall, E.S. Shcherbakova, S.I. Sitkin, T.Ya. Vakhitov, I.G. Bakulin, E.V. Demyanova. Molecular mechanisms of non-alcoholic fatty liver disease development. Profilakticheskaya meditsina 2021; 24(4): 120 doi: 10.17116/profmed202124041120
|
| 28 |
Cheng Fang, Qingwu Zhou, Qingyang Liu, Wei Jia, Yan Xu. Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding. Food & Function 2022; 13(2): 596 doi: 10.1039/D1FO02892H
|
| 29 |
Shi-Qing Zhao, Hui-Ling Zheng, Xiao-Tian Zhong, Zi-Ye Wang, Yi Su, Yan-Yan Shi. Effects and mechanisms of <i>Helicobacter pylori</i> infection on the occurrence of extra-gastric tumors. World Journal of Gastroenterology 2024; 30(37): 4090-4103 doi: 10.3748/wjg.v30.i37.4090
|
| 30 |
Rashid Abdel-Razeq, Lynn Bitar, Elio R Bitar, Chidera Onwuzo, Mohamad-Noor Abu-Hammour, Barish Eren, Islam Mohamed, Adejoke Johnson, Antoine Boustany, Somtochukwu Onwuzo, Imad Asaad. Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study. World Journal of Hepatology 2024; 16(10): 1349 doi: 10.4254/wjh.v16.i10.1349
|
| 31 |
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan. Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023). Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1342356
|
| 32 |
Chen Chen, Caiyun Zhang, Xuelin Wang, Feijuan Zhang, Ze Zhang, Pengchai Ma, Shuzhi Feng. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. European Journal of Gastroenterology & Hepatology 2020; 32(7): 857 doi: 10.1097/MEG.0000000000001601
|
| 33 |
Sohaib Bin Wahid, Muhammad Waqar, Zobaria Rehman, Muhammad Wasim, Muhammad Idrees. Prevalence of HCV-Helicobacter pylori co-infection and its effects on liver function enzymes of patients in Lahore, Pakistan. BioScientific Review 2019; 1(03): 09 doi: 10.32350/BSR.0103.02
|
| 34 |
Osman Özdoğan, Serkan Yaras. Helicobacter pylori rate and histopathological evaluation in HBeAg-negative chronic hepatitis B virus infection. Archives of Medical Science – Civilization Diseases 2019; 4(1): 97 doi: 10.5114/amscd.2019.91449
|
| 35 |
Tomoka Matsuura, Satoko Ohfuji, Masaru Enomoto, Akihiro Tamori, Shoji Kubo, Kiyohide Kioka, Norifumi Kawada, Wakaba Fukushima. Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol. JGH Open 2020; 4(5): 867 doi: 10.1002/jgh3.12331
|
| 36 |
Linghua Yu, Linlin Wang, Huixing Yi, Xiaojun Wu. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model. Gut Microbes 2020; 11(4): 1015 doi: 10.1080/19490976.2020.1736457
|
| 37 |
Xue Feng, Lu Han, Sijia Ma, Lanbo Zhao, Lei Wang, Kailu Zhang, Panyue Yin, Lin Guo, Wei Jing, Qiling Li. Microbes in Tumoral In Situ Tissues and in Tumorigenesis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.572570
|
| 38 |
Ben‐Gang Zhou, Huai‐Jie Yang, Wei Xu, Kai Wang, Peng Guo, Yao‐Wei Ai. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies. Helicobacter 2019; 24(3) doi: 10.1111/hel.12576
|
| 39 |
Qifang Sun, Chengzhi Yuan, Sainan Zhou, Jing Lu, Meiyan Zeng, Xiong Cai, Houpan Song. Helicobacter pylori infection: a dynamic process from diagnosis to treatment. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1257817
|
| 40 |
Ancuta Lupu, Ingrith Crenguta Miron, Anca Lavinia Cianga, Andrei Tudor Cernomaz, Vasile Valeriu Lupu, Cristina Gavrilovici, Iuliana Magdalena Stârcea, Elena Tarca, Dragos Catalin Ghica, Silvia Fotea. The Prevalence of Liver Cytolysis in Children with Helicobacter pylori Infection. Children 2022; 9(10): 1498 doi: 10.3390/children9101498
|
| 41 |
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei. The possible role of Helicobacter pylori in liver diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03602-z
|
| 42 |
Junjian He, Yunyi Liu, Qin Ouyang, Rongxing Li, Jie Li, Weiyan Chen, Weichao Hu, Lijiao He, Qiyu Bao, Ping Li, Changjiang Hu. Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.972777
|
| 43 |
Tatyana KUGLER, Gennady TARADIN. HELICOBACTER AND HEPATOBILIARY DISEASES: UPDATE 2023. Arquivos de Gastroenterologia 2023; 60(2): 271 doi: 10.1590/s0004-2803.202302023-15
|
| 44 |
Ru Zheng, Heng-Liang Zhu, Bing-Ren Hu, Xiao-Jiao Ruan, Hua-Jie Cai. Identification of <i>APEX2</i> as an oncogene in liver cancer. World Journal of Clinical Cases 2020; 8(14): 2917-2929 doi: 10.12998/wjcc.v8.i14.2917
|